Gilead Sciences, Inc.
GILD
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment ofā¦ read more
Healthcare
Drug ManufacturersāGeneral
33 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$115.44
Price+2.37%
$2.67
1Y
Price
Market Cap
$143.238b
Large
Price/Earnings 3y Avg5y Avg
14.9x
Premium
Premium
Financials Overview
Key metrics over the past few years+47.7%
EBITDA Margin+27.7%
Net Profit Margin+10.2%
Free Cash Flow MarginRevenue
$28.862b
+0.4%
1y CAGR+1.9%
3y CAGR+1.4%
5y CAGREarnings
$6.311b
+1214.8%
1y CAGR+382.2%
3y CAGR+280.1%
5y CAGREPS
$5.02
+1221.1%
1y CAGR+384.4%
3y CAGR+281.7%
5y CAGRBook Value
$19.591b
$55.721b
Assets$36.130b
Liabilities$24.946b
DebtDebt to Assets
44.8%
2.3x
Debt to EBITDAFree Cash Flow
$9.369b
-9.1%
1y CAGR+6.2%
3y CAGR-1.0%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company